CECILIA OLIVAS: Open Payments
NPI 1912140245 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 33 payments from 10 companies in 2025. Trend: 2023 $283 · 2024 $625 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $205 |
| Neurelis, Inc. | 4 | $182 |
| UCB, Inc. | 6 | $138 |
| Genentech USA, Inc. | 2 | $59 |
| Janssen Biotech, Inc. | 2 | $55 |
| Merz Pharmaceuticals, LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| SK Life Science, Inc. | 1 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
Products named: UBRELVY, VALTOCO, BOTOX, Ocrevus Zunovo, Briviact, QULIPTA, Xeomin, Fintepla.
Industry payments across TX — which companies pay providers there.
